A Mimic of Tumor Rejection Antigen-Associated Carbohydrates Mediates an Antitumor Cellular Response

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Research

• Publication date

  2004-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-03-1532PMID 15026358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Processing of glycans on glycoprotein and glycopeptide antigens in antigen-presenting cells

  2002cited by this paper
• Immunization with a carbohydrate mimicking peptide augments tumor-specific cellular responses.

  2001cited by this paper
• T Cells Activated by Zwitterionic Molecules Prevent Abscesses Induced by Pathogenic Bacteria*

  2000cited by this paper
• Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo.

  2000cited by this paper
• Tumor Vaccination That Enhances Antitumor T-Cell Responses Does Not Inhibit the Growth of Established Tumors Even in Combination With Interleukin-12 Treatment: The Importance of Inducing Intratumoral T-Cell Migration

  2000influential reference
• From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix.

  2000cited by this paper
• From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines

  2000cited by this paper
• Presentation of Cytosolic Glycosylated Peptides by Human Class I Major Histocompatibility Complex Molecules in Vivo

  1999cited by this paper
• Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses

  1999cited by this paper
• Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccine.

  1999cited by this paper
• Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity.

  1999cited by this paper
• Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL.

  1999cited by this paper
• T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity.

  1997cited by this paper
• Carbohydrate and peptide specificity of MHC class II-restricted T cell hybridomas raised against an O-glycosylated self peptide.

  1997cited by this paper
• Therapy of murine tumors with p53 wild-type and mutant sequence peptide- based vaccines

  1996cited by this paper
• Immunization with glycosylated Kb‐binding peptides generates carbohydrate‐specific, unrestricted cytotoxic T cells

  1996cited by this paper
• T cell recognition of Tn‐glycosylated peptide antigens

  1996cited by this paper
• IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones.

  1996cited by this paper
• Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma.

  1995cited by this paper
• GD2 oligosaccharide: target for cytotoxic T lymphocytes

  1995cited by this paper
• Recognition of carbohydrate by major histocompatibility complex class I- restricted, glycopeptide-specific cytotoxic T lymphocytes

  1994cited by this paper
• IL-12 receptor. II. Distribution and regulation of receptor expression.

  1992cited by this paper

• O-GlcNAcylation and immune cell signaling: A review of known and a preview of unknown

  2024cites this paper
• O-GlcNAcylation in cancer development and immunotherapy.

  2023cites this paper
• Harnessing Antibody Polyspecificity for Cancer Immunotherapy

  2022cites this paper
• P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses

  2021cites this paper
• Antigens: CarbohydratesII

  2020cites this paper
• Human DKK1 and human HSP70 fusion DNA vaccine induces an effective anti-tumor efficacy in murine multiple myeloma

  2017cites this paper
• Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects

  2017cites this paper
• Peptide mimics of a carbohydrate‑associated epitope expressed by cancer cells: Identification of vaccine candidates.

  2016cites this paper
• Antibodies at the Center of Immunotherapy: Commentary on âÂÂMoving a Carbohydrate Mimetic Peptide into the ClinicâÂÂ

  2016cites this paper
• Moving a Carbohydrate Mimetic Peptide into the clinic

  2015cites this paper
• Synthesis of cyclic peptide natural products and peptidomimetics

  2015cites this paper
• Antibodies: At The Nexus of Antigens and Cancer Vaccines.

  2015cites this paper
• Defining and managing expectations for early immunotherapy cancer trials.

  2015cites this paper
• Carbohydrate-Mimetic Peptides for Pan Anti-Tumor Responses

  2014cites this paper
• Tumor-Associated Glycans and Immune Surveillance

  2013cites this paper
• The promise of the anti-idiotype concept

  2012cites this paper
• Glycan mediated immune responses to tumor cells

  2011cites this paper
• Carbohydrate Mimetic Peptides Augment Carbohydrate-Reactive Immune Responses in the Absence of Immune Pathology

  2011influential citation
• Cancer vaccine with mimotopes of tumor-associated carbohydrate antigens

  2010cites this paper
• Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans

  2010cites this paper
• RNA‐mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation

  2010cites this paper
• Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.

  2009cites this paper
• The new face of nucleolin in human melanoma

  2009cites this paper
• Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes.

  2009cites this paper
• Immunization with a Mimotope of GD2 Ganglioside Induces CD8+ T Cells That Recognize Cell Adhesion Molecules on Tumor Cells1

  2008influential citation
• Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.

  2008cites this paper
• Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice

  2008cites this paper
• Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma.

  2007cites this paper
• Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery

  2007cites this paper
• Peptide mimotopes as prototypic templates of broad-spectrum surrogates of carbohydrate antigens for cancer vaccination.

  2007cites this paper
• Immune Surveillance as a Rationale for Immunotherapy?

  2007cites this paper
• Vaccination of High-Risk Breast Cancer Patients with Carbohydrate Mimicking Peptides

  2007cites this paper
• Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine.

  2006cites this paper
• Design of peptide-based vaccines for cancer.

  2006cites this paper
• Reduction of Spontaneous Metastases through Induction of Carbohydrate Cross-Reactive Apoptotic Antibodies1

  2005cites this paper
• Epitope-specific antibody response to Mel-CAM induced by mimotope immunization.

  2005cites this paper
• Human tumor associated antigen mimicry by xenoantigens, anti-idiotypic antibodies and peptide mimics: implications for immunotherapy of malignant diseases.

  2005cites this paper
• Chitinases and peptide mimotopes.

  2005cites this paper
• Cross-Reactive Apoptotic Antibodies through Induction of Carbohydrate Reduction of Spontaneous Metastases

  2005cites this paper
• Carbohydrate Moieties as Vaccine Candidates

  2005cites this paper
• Carbohydrate mimotopes in the rational design of cancer vaccines.

  2005cites this paper